Silence Therapeutics (SLN) Other Non Operating Income (2020 - 2025)
Historic Other Non Operating Income for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $1.9 million.
- Silence Therapeutics' Other Non Operating Income rose 11697.09% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 15486.82%. This contributed to the annual value of $4.5 million for FY2024, which is 26932.98% up from last year.
- As of Q3 2025, Silence Therapeutics' Other Non Operating Income stood at $1.9 million, which was up 11697.09% from -$6.6 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Other Non Operating Income ranged from a high of $357.1 million in Q1 2021 and a low of -$357.0 million during Q3 2021
- For the 5-year period, Silence Therapeutics' Other Non Operating Income averaged around -$311203.5, with its median value being -$106492.8 (2021).
- Over the last 5 years, Silence Therapeutics' Other Non Operating Income had its largest YoY gain of 55326.31% in 2024, and its largest YoY loss of 160951.57% in 2024.
- Quarter analysis of 5 years shows Silence Therapeutics' Other Non Operating Income stood at -$106492.8 in 2021, then crashed by 434.19% to -$568870.2 in 2022, then crashed by 587.04% to -$3.9 million in 2023, then soared by 502.67% to $15.7 million in 2024, then tumbled by 87.71% to $1.9 million in 2025.
- Its last three reported values are $1.9 million in Q3 2025, -$6.6 million for Q2 2025, and -$3.8 million during Q1 2025.